A Yilmaz1, Fu Malya2, G Ozturk1, B Citgez2, Y Ozdenkaya1, C Ersavas1, Af Agan3, H Senturk4, O Karatepe1. 1. Department of Surgery, Medipol University Turkey. 2. Department of Surgery, Bezmialem University Turkey. 3. Department of Gastroenterology, Medipol University Turkey. 4. Department of Gastroenterology, Bezmialem University Turkey.
Abstract
BACKGROUND: The red blood cell distribution (RDW) is a test measure of erythrocyte variation and the volume level which shows the heterogeneity and it is a proven test in literature for the determination of survival on cardiovascular diseases. The main purpose of this research is to investigate the relationship between the RDW level and postoperative morbidity as well as its stages in diagnosed pancreatic cancer patients. METHODS: In this study we covered 104 diagnosed pancreatic cancer patients who have been operated in 2011-2014. The RDW levels were separated into two groups. Group 1 contains higher level RDW patients (> 14) whereas group 2 contains only lower level RDW patients. We compared both groups in terms of the patients' demographic data, duration of hospitalization, ratio of pancreatic fistula, disease period, and the mortality rates. RESULTS: In group 1 contains 39 patients whereas group 2 contains only 65 patients. We determined the positive correlation between stages of disease with RDW levels as well as the correlation between low level of blood albumin and Ca 19.9 levels (p = 0001). However we did not observe statistically important difference in postoperative morbidity. CONCLUSIONS: Based on this study we report that RDW levels can be use as a marker to show the stages of pancreatic cancer in diagnosed patients.
BACKGROUND: The red blood cell distribution (RDW) is a test measure of erythrocyte variation and the volume level which shows the heterogeneity and it is a proven test in literature for the determination of survival on cardiovascular diseases. The main purpose of this research is to investigate the relationship between the RDW level and postoperative morbidity as well as its stages in diagnosed pancreatic cancerpatients. METHODS: In this study we covered 104 diagnosed pancreatic cancerpatients who have been operated in 2011-2014. The RDW levels were separated into two groups. Group 1 contains higher level RDW patients (> 14) whereas group 2 contains only lower level RDW patients. We compared both groups in terms of the patients' demographic data, duration of hospitalization, ratio of pancreatic fistula, disease period, and the mortality rates. RESULTS: In group 1 contains 39 patients whereas group 2 contains only 65 patients. We determined the positive correlation between stages of disease with RDW levels as well as the correlation between low level of blood albumin and Ca 19.9 levels (p = 0001). However we did not observe statistically important difference in postoperative morbidity. CONCLUSIONS: Based on this study we report that RDW levels can be use as a marker to show the stages of pancreatic cancer in diagnosed patients.
Entities:
Keywords:
Pancreatic cancer; red cell distrıbution; stage
Authors: Brydon J B Grant; Deepa P Kudalkar; Paola Muti; Susan E McCann; Maurizio Trevisan; Jo L Freudenheim; Holger J Schünemann Journal: Chest Date: 2003-08 Impact factor: 9.410
Authors: Kushang V Patel; Richard D Semba; Luigi Ferrucci; Anne B Newman; Linda P Fried; Robert B Wallace; Stefania Bandinelli; Caroline S Phillips; Binbing Yu; Stephanie Connelly; Michael G Shlipak; Paulo H M Chaves; Lenore J Launer; William B Ershler; Tamara B Harris; Dan L Longo; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2009-10-30 Impact factor: 6.053
Authors: Amanda V Hayman; Susan J Stocker; Marshall S Baker; David J Bentrem; Richard A Prinz; Robert de W Marsh; Mark S Talamonti Journal: Am J Clin Oncol Date: 2014-12 Impact factor: 2.339
Authors: Stephanie E Combs; Daniel Habermehl; Kerstin A Kessel; Frank Bergmann; Jens Werner; Patrick Naumann; Dirk Jäger; Markus W Büchler; Jürgen Debus Journal: Ann Surg Oncol Date: 2014-06-11 Impact factor: 5.344